Skip to main content
Premium Trial:

Request an Annual Quote

9th Annual Salary Survey


The global economy is still shaky. It seems that each week there are reports of improved economic indicators, followed closely by reports of setbacks. In the US, the national unemployment rate is down from its 2009 high — but not by much. In the research field, however, unemployment appears to have dropped, according to Genome Technology's latest salary survey. At the height of the economic crisis, 3.17 percent of respondents to 2009's survey indicated that they were unemployed; this year only 0.7 percent did.

To gather all the data on these pages, Genome Technology e-mailed a survey link to subscribers in late April, and followed up with a second e-mail a week later to those who had not taken the survey. All told, 1,870 people responded to GT's questions about salary and benefits.


Overall, salaries reported this year are about the same as those reported five years ago. In both 2006 and 2011, senior scientists at small pharmas or biotechs reported making a median of $50,000 to $74,999. Similarly, associate professors at universities or medical centers reported earning a median of $75,000 to $99,999. Some positions — like VP-level jobs at mid- or large-sized pharmas or biotechs — saw salary increases while others — including staff scientists at small pharmas or biotechs — saw a decrease in pay.

This year, GT also broke the salary data down by reported gender, to try to determine whether there are any differences in pay for men and women. Broadly, it appears that indeed there are, even when years of experience are controlled for.

It's not all gloom and doom, however; about 60 percent of respondents say they expect a raise this year and about a quarter expect a promotion. Read on to find out more:

Number of Respondents: 1,870
Females: 35.6%
Males: 64.4%

Primary Background.jpg




Type of Organization.jpg

Job Title.jpg


Reason for Leaving last Job.jpg

Years Current Job.jpg


Region by Org.jpg

Raises Expected By Organization.jpg

Layoff and Paycuts by Organization.jpg

Moving on and up.jpg
[click image to enlarge]

Median Salary by Region.jpg
[click image to enlarge]

Median Salary by Gender.jpg
[click image to enlarge]

Median Salary by Title.jpg
Web-Only Extras


Of academic respondents have tenure

Of respondent say last employer is no longer in business

Say organization has had layoffs in the past year

Have had a pay cut in the last year

Were laid off in the past year

Are unemployed

Are employed full-time

Have been at their current job for 1-4 years

Most common benefits
Medical/dental insurance
Retirement plan, including 401(k)s, 403(b)s, pensions
Annual bonus
Continuing education or tuition benefit

Most common scientific task
Biostatistics/data analysis
DNA sequencing
Microarray analysis or gene expression
PCR or PCR-related tasks

Most common educational levels

Most common remuneration for inventions
Ownership of the patent

Salary from Grants.jpg

File Attachments
The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.